Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: Is there dependency on nuclear factor-κB and receptor activator of nuclear factor κB (RANK)/RANK ligand signaling?

Bone

Volumn 28, Issue 4, 2001, Pages 378-386

  Van Bezooijen, R L ^a   Papapoulos, S E ^a   Lowik C W G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Interleukin 17 (IL 17); Nitric oxide (NO); Nuclear factor B (NF B); Osteoclastic bone resorption; Receptor activator of nuclear factor B (RANK); Tumor necrosis factor (TNF )

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN RECEPTOR; INTERLEUKIN 17; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PYRROLIDINE DITHIOCARBAMATE; RECEPTOR; RECOMBINANT INTERLEUKIN 17; RECOMBINANT OSTEOPROTEGRIN; RECOMBINANT PROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALVARIA; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; FETUS; IN VITRO STUDY; METATARSAL BONE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BONE RESORPTION; CARRIER PROTEINS; INTERLEUKIN-17; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; NITRIC OXIDE; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035033873     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00457-9     Document Type: Article

References (52)

1. Interleukin-17 upregulation of nitric oxide production in human osteoarthritis cartilage
2. Required and nonessential functions of nuclear factor-κB in bone cells
3. Single-step method RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
4. Cytokines induce nitric oxide production in mouse osteoblasts
5. Expression of vascular endothelial growth factors (VEFFs) and their receptors during osteoblast differentiation
6. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages
7. RANK is essential for osteoclast and lymph node development
8. Cloning of the p50 DNA binding subunit of NF-kappa-B; Homology to rel and dorsal
9. 15N]nitrate in biological fluids
10. The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli
11. The role of reactive oxygen intermediates in osteoclastic bone resorption
12. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity
13. Osteopetrosis in mice lacking NF-κB1 and NF-κB2
14. N-Acetyl-L-cysteine enhances interleukin-1β-induced nitric oxide synthase expression
15. Interleukin-17 stimulates the expression of IkBa mRNA and the secretion of IL-6 and IL-8 in glioblastoma cell lines
16. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
17. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
18. Cloning of the murine relA (NF-kappaB) gene and comparison to the human gene reveals a distinct first intron
19. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA
20. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption
21. Osteoclastic inhibition; An action of nitric oxide not mediated by cyclic GMP
22. Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes; Possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK)
23. - production as a sensitive and rapid assay for the quantitation of murine IFN-γ
24. In vitro and ex vivo evidence that estrogen suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis
25. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand; Modulation of the expression by osteotropic factors and cytokines
26. NF-κB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells
27. 2-microglobulin genes
28. Genomic organization and chromosomal mapping of mouse nuclear factor kappa B2 (NFKB2)
29. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
30. Nitric oxide and bone; What a gas!
31. Mechanisms of cytokine induced bone resorption; Role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins
32. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase
33. Expression and functional role of nitric oxide synthase in osteoblast-like cells
34. Mechanisms controlling nitric oxide synthesis in osteoblasts
35. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB
36. An invitation to an open exchange of reagents and information useful for the measurement of cytokine mRNA levels by PCR
37. Sodium nitroprusside increases cyclic GMP in fetal rat bone cells and inhibits resorption of fetal rat limb bones
38. In vitro differentiation and calcification in a new clonal derived osteogenic cell line derived from newborn mouse calvaria
39. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro; A clue to the mechanism of action of nitrogen-containing bisphosphonates
40. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture
41. IL-1α, IL-1β, IL-6, and TNF-α steady state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice
42. Interleukin-17; A new bone acting cytokine in vitro
43. Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4